REGN
Regeneron Pharmaceuticals Inc
Mentions (24Hr)
0.00% Today
Reddit Posts
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
Promising Penny Stocks $CMRA, $FCF, $NOTE
If I wanted to bet on Dupixent, is REGN or SNY the way to go?
Sanofi Q1 profit climbs on Dupixent as drug on track for €10B this year (NASDAQ:REGN)
Dow Jones futures rise; a sale at Silicon Valley Bank closes; Microsoft, Tesla near buy points
Regeneron stock wins bullish views on Dupixent data (NASDAQ:REGN)
Can someone please help explain these numbers to me?
Regeneron posts Q4 beat as COVID therapy offset Eylea impact (NASDAQ:REGN)
I've been offered my end of the year bonus in cash or company stock, what would others do?
REGN —that’s a real live short squeeze
REGN just doesn’t give a fuck. Rocket time.
$REGN to retest 52 wk lows with the market? 🤞 #doyoubleed 📉🩸🧛♂️🚀
And here I was starting to feel bullish on REGN..
Checkmate (CMPI.US) soared 328% before the market Acquired by Regeneron Pharmaceuticals (RENG.US) at a premium
Searing Criticism on ARK's Genomic Bets in FT. What do you think?
Regeneron (REGN), Thermo Fischer (TMO), Danaher (DHR) and Vertex (VRTX)
$4.5B market cap Biotech with at least 3.5B confirmed sales in 2022. What???
Is Ken Griffin pushing $REGN calls to avoid Marge? Could regeneron failing to be picked up by various governments be the key to MOASS?
For those who placed puts on MRNA/BNTX/REGN because of MRK data
For those who placed puts on MRNA/BNTX/REGN because of MRK data
$BIIB EXTREMELY OVERSOLD. BLOODBATH UNWARRANTED
One year in trading options. To the moon then to earths fucking core then back to the moon (for now). Almost exclusively $REGN
First in-vivo gene editing therapy announces positive results
$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR
$NTLA and $REGN announce that they have successfully corrected a hereditary disease with an infusion of CRISPR
REGENERON received FDA clearancefor reduced dosage for COVID-19 treatment
Vaccine Hesitancy and How to Profit from it: Vaxart
Vaccine Hesitancy and How to Profit from It (Vaxart)
Should I sell REGN?? What do you think?
Viatris (VTRS) recommended as one of 5 v undervalued Pharma stocks in Barrons today
Why did the stock price go down after the FDA approval?
Mentions
What’s everyone think of REGN?
Anyone else in REGN? 250 shares
People have made good money on the weight loss drugs. REGN solves the problem of people loosing too much muscle and will be the preferred method.
I read the fall was because of "Friday, May 30, in the wake of the unexpected failure of itepekimab, its chronic obstructive pulmonary disease (COPD) treatment in conjunction with Sanofi, during a late-stage clinical trial. " However "From a valuation standpoint, the stock seems undervalued, indicating an attractive entry point for investors. We believe there is little reason for long-term concern with REGN stock, rendering its current valuation notably low.... From a valuation standpoint, the stock seems undervalued, indicating an attractive entry point for investors. We believe there is little reason for long-term concern with REGN stock, rendering its current valuation notably low." I did some similar quick scans and the consensus is that it's undervalued, however the recent failures of their trials lost them significant potential revenue. A moderate buy is warranted until better news arrives.
I bought REGN 4-5 years ago, I thought I’d hold it for 5-10 years so didn’t sell when it hit ATH which 2X+ from when I bought. Now it’s all the way back to when I bought. Was I supposed to sell? It's hard to giver advice on 1 stock. This about investing, this is not WSB, and the concept of investing comprises the concept of diversification and asset allocation.
I bought REGN 4-5 years ago, I thought I’d hold it for 5-10 years so didn’t sell when it hit ATH which 2X+ from when I bought. Now it’s all the way back to when I bought. Was I supposed to sell?
Anyone else been buying REGN around $500?
>the vast vast majority of profits come from a small percentage of them It seems REGN was in the large percentage bucket. That's why you diversify
What was the reason that REGN lost its value? You should be following the narrative behind the price action to determine if it’s worth holding.
Depends on whether you think REGN is a good long term hold for decades. If it is then it literally doesn't matter that it went up 2x and then went back. I only buy stocks I believe are going to be successful 20-30 years from now. You're never going to time all your stocks correctly and I'd rather have one stock that goes up 20x while 6 other stocks go nowhere. Trying to time buy and sell on 6 stocks is not worth losing out on one 20x gains.
REGN just might not be your NVDA
I could use some words from you, friend. I bought REGN 4-5 years ago. It went up more than 2X but I didn’t take profit because I wanted to hold it for “decades”. Well, now it’s back to where I started. I’m having a bit of a hard time dealing with this. Any thoughts?
Significantly depends on the kind of addressable audience, how much the stock has run up into approval, how much is it going to take (for a company already going through $) to get to launch, what is broader sentiment in biotech (generally varying degrees of bad for a while, especially given continued higher rates), etc etc etc. There's so many factors, it's not just approval = x%. I've owned a number of biotech names and have done reasonably well (have had 3 buyouts this year alone), but it's a very hard sector to do well in and much harder to do consistently well. There's also so much focus on whether something gets bought out or not; you can have an approval and still have a smaller company mismanage things. Few people are hoping that their biotech is the next Regeneron because very, very few biotechs become the next REGN (or VRTX, or ARGX another example) - the good stuff is mostly picked over by big pharma when they need to refill their pipeline. Also, too many people pile into micro cap biotechs because they told a good story and then it turns out to be less/a lot less than advertised. It's a lot easier (at least IMHO) to buy things that are already on the 50 yard line and you think have a reasonable chance of touchdown or at least a kicking a field goal. That said, if something that a lot of people think might be a buyout candidate even hints that's not happening anytime soon, people flee in a manner that I don't think many investors are used to. With healthcare in general, I think that it's very much "what's next" and if there isn't something compelling on deck then you see selling like NVO, or GILD around 10 years ago going from a very hot stock to something that didn't see the highs of the mid 2010's again until recently. Overall, I have materially less in biotech than what I started the year with.
Yes I keep buying below $76. REGN looks like another opportunity as well.
Me watching my UNH leaps finally turn green 🫡 Wish I could say the same for REGN 😔
I did this and lost all my profit. Bought REGN in 2021, it doubled and some and now back to where it was 4 years ago.
How much would that have been worth today? I bought REGN 4 years ago. It doubled and some but I didn’t sell even a single share because I didn’t need the money last year and it still showed potential. And now it’s back to where it was 4 years ago. What was all that for? I’m hoping it’ll go back at least half way but who knows. It was a lot of gains I could’ve had though. How to cope with this?
REGN up 3.06% so far today, be interesting to see if it follows the UNH trend of massive drop and then fairly sharp rise (but still net loss).
ask me again in a couple months. trying this on REGN
bought some REGN @ the low today… good value mate
REGN and UNH going to the moon, you heard it here first 
REGN - it continues to bite me in the ass - another 10% down last week!
Any hope for REGN? Or are has it been luigi'd as well?
Yes I also went in on UNH today. Can't deny a P\E Ratio of 12! Have you looked at REGN? Also highly undervalued at these levels. Options on REGR a little expensive but it may be worth it!
REGN is down 60% in 9 months, including 19% last week. Not sure if it’s bottomed but it’s probably close
I’m all in REGN UNH 
Yeah I was just looking at REGN, going to keep an eye on it
Anyone catching the knives on REGN? Trailing P/E of 14.44 Forward P/E of 16.27 PEG ratio of 1.48 Net margin of 31.95% and gross margin of 85.79% Down 20% today.
$12B MC haircut (19%) seems like an exaggerated reaction to REGN’s failed COPD drug.
What the actual fuck is happening to REGN?
https://finance.yahoo.com/quote/REGN/holders/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAKQaWqvWlkyDlJpV5WxYSsM8TqEAUyfs2iJbaWE4YVYvooOE7fg0ghg6LCo-XnuDX11oUWSaRU4l5JmGrGqePzIjBqm8L4bX71k_uomXcNVbPjShAnt17e49lzvbc7hoRM60R7nPa0F5OI5G0itLJqI0kBh4XFLgxtg09bn0ZAAI They are private equity
https://finance.yahoo.com/quote/REGN/holders/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAKQaWqvWlkyDlJpV5WxYSsM8TqEAUyfs2iJbaWE4YVYvooOE7fg0ghg6LCo-XnuDX11oUWSaRU4l5JmGrGqePzIjBqm8L4bX71k_uomXcNVbPjShAnt17e49lzvbc7hoRM60R7nPa0F5OI5G0itLJqI0kBh4XFLgxtg09bn0ZAAI
VRDN RZLT AKRO VRTX SRPT REGN My biotech longs
Stocks that look interesting in terms of price vs stage to me: HSDT AFMD CYTK REGN I haven’t researched into them
why is everyone sleeping on REGN
Can someone explain why REGN is in the shitter?
Pay Attention to AMGN, REGN - If trump, as politico reported, announces drug price cuts for Medicare part B, this stocks will take a hit.
Sure glad I bought dog shit REGN instead of LLY
I’m in HRMY and LNTH. I’m looking at REGN and BMY here
Fun game: look for tickers that could plausibly go to $420/share before SPY, but aren't yet so close it's a gimmie. I think my top picks for this game are **GS** ($470.13, down -18.12% YTD) and **META** ($504.73, down -15.77% YTD), to stocks that are eminently hatable for different reasons. But there's also **MA** ($489.77, -6.25% YTD) which was doing okay at the start of the year but recently took a huge hit, I think because it may have just suffered a huge setback in its battle for market share not just with Visa but also non-US competitors. Then there's the ones that might actually avoid the fate. Pharmaceutical companies **REGN** ($572.91, -19.82% YTD) and **VRTX** ($474.35, *up +*16.97% YTD, remarkably in this market) are definitely in the danger zone but feel like ones that could moon if we get another pandemic courtesy of RFK Jr. There's also **UNH** ($525.42, up +4.07% YTD) and **INTU** ($561.53, -9.84% YTD) which may benefit from the current administration being a great time to be a total scumbag of a company. Finally, there's **NOC** ($484.96, +3.74% YTD) and **BRK.B** ($493.70, +9.41%), whose share prices put them in the danger zone but which have been less volatile than most stocks, probably due to the eternal profitability of war (for NOC) and a stodgy, fundamentals-driven investing philosophy (BRK.B). Anyone else have suggestions for this game?
Nice choices. I’ve been eyeing REGN for a while, it looks dirt cheap. However, not sure I understand enough about the loss of patents to invest big in it
I don't see a lot of glaring opportunities right now, even after this big pre-market drop. Prices are basically back to where they were on Monday? As of right now, I plan to add to ASML, GOOGL maybe, NU if it goes below $10, and REGN.
It’s all about risk. Any investment that provides the possibility of more gains also has the risk of more losses. I’ll be downvoted for this, but I’m going to tell you my experience, which is completely contrary to the common wisdom, but is what you’re asking about. My parents raised me to invest, and their number one rule was to never buy funds, only invest in individual stocks. But also, never try to time or trade; take the time to learn about companies and industries, invest small amounts in the ones you are convinced will grow, and then never sell. Over decades a few of these companies experience massive growth, while most of them grow only a little. My parents bought shares of maybe 50 companies, only a few thousand dollars in each. The ones that took off—AAPL, REGN, LLY, BDX and a few others—are now worth many millions. In the long term the success of these few companies makes all the companies with small gains or losses unimportant, more like a rounding error. If you invest in the S&P you get the few good companies, but you also get thousands of companies that don’t do much. All you need to do to beat the market is buy a couple of the winners and fewer than the thousands of losers you’d get in a fund. I’m now managing my parents’ investments in the family trust, as well as my own, and over the last 15 years we’ve easily doubled the growth of the S&P. There was luck involved. We’re not geniuses. Many would say—with justification—that I’m an idiot. But we’ve learned to simply be patient, to occasionally buy small amounts of promising companies, and never sell anything.
A lot more losers than winners, but here were the bright spots for me: REGN +5.27% NEE +4.57% SNDK +3.92% BMY +3.3 ED +2.9% ADM +2.36% CI +1.76% KR +1.5%
My dividend paying short list is rising, or barely falling. They seem to be where money is flowing. I wish they would fall so I could buy on sale. Growth getting hammered. Is it the time to buy NVDA? I think yes, but could easily fall more. Up today on my short list $EPD, $T, $MO $REGN up more than 5%, and I can’t see any news I bought some $BIP & $MSDL today. High flyers will bottom at some point
REGN resurrecting my port
REGN and STZ for legit businesses that will rebound over time. Everything else I see here is the typical momentum stock.
Dr just told me the FDA just inspected the manufacturing facility for the second time for $REGN’s Linvoseltamab. Approval any day now she says, but with 🥭 cuts I dunno. Probably going to buy some more $REGN myself.
Long term REGN and STZ are both at big discounts
REGN has a 0.14 beta with 40.41 EPS and a 17 P/E. every portfolio should be loaded with it
REGN calls? Seems oversold and quite a drug portfolio
Listen up gourds, REGN is on sale half price. I’ve been in the REGN5458 trial for almost 3 years, it completely eradicated my blood cancer after 7 years of everything else failed. Zero side effects, no need for any other drugs including no steroids. My doctor keeps telling me it’s going to be approved any day now (could be months and who knows with the .gov shake up going on). I’m buying back in tomorrow. This drug is putting 2x-3x the number of patients in remission vs the leading front line treatment drug Darzalex. Darzalex had a revenue of $8B in 2023 and probably significantly more in 2024.
Wow, VRTX and REGN continue to just get obliterated. I’m very interested here
The FDA approval that CKPT ($3.67) received late last night is going to significantly affect the future earnings for REGN MRK & BMY. The FDA approval that CKPT received last night was for Unloxcyt, which is superior to Regeneron’s Libtayo and Merck’s Keytruda. In fact, the Complete Response rate for Unloxcyt is nearly double that of Keytruda’s. Keytruda is obviously the # 1 drug on the planet generating nearly 30 billion in revenue each year for Merck. Libtayo is approved for 3 indications, and CKPT will easily replace Libtayo. CKPT will also begin targeting the 40 indications that Keytruda is currently approved for, and since Keytruda accounts for 45% of Merck’s total revenue, this is going to really impact them as a company. It will be a good idea to short these companies before their earnings.
Thank you for that insight. It helps explain some of the disparities I see in high-priced tickers like COST and REGN.
LLY resurrected the port. Sold perhaps a little early as was leveraged to the tits but desperately needed the dub. Grabbed a couple at close though and more of that piece of shit REGN
REGN continues to get obliterated
Opened a small position in REGN and BMY today. I really like some pharmaceutical/Biotech names right now
> Anything interesting as far as value goes? Obliterated large cap biotech (REGN, BIIB), European luxury (primarily the highest quality - LVMUY; a lot of the rest is a hope for an uncertain turnaround in things like Burberry and Kering), alcohol (REMYY, DEO, etc), refiners (MPC, VLO - although less so than a couple weeks ago) and some Canadian stuff (Stella Jones down close to 30% recently and some insider buying - https://pbs.twimg.com/media/Gc8kZGnaAAQTMO0?format=png&name=900x900)
I owned like 16k shares of REGN as a penny stock. Sold it at $22.
> My concern is mostly with how quickly they are losing value in their stock. Similar drawdown in 2021-2022, although that was over several months, not three. Nothing more than mere opinion, but it just feels like that's the way the market increasingly is - if something isn't working, it just feels like it's sold in that fashion. It deserved to be sold after that quarter, but the nature of how some things are sold in the last year or three feels different; you get a dump, blip, then it just keeps on selling as if it's a buyer's strike. Elsewhere in health care, REGN another instance of bad news and selling that is reasonable to a point and then starts to seem almost indiscriminate. I get that people believe solar will struggle under the new administration, but a stock like ENPH down 30% into the election goes down another 33% in the 10 days after? There were a number of names up 30-40-50-70% after the election. Again, nothing more than mere opinion, but the market at both extremes feels different than it used to 5 years ago. What works is bought to the point of starting to seem indiscriminate and what doesn't is sold to the point of starting to seem indiscriminate. Do I know where the bottom is for ICLR? No idea, but I think when you get these names with RSIs in the teens (technically oversold to the point of being near-obliterated), it's time to at least start a position and average down if you have a medium term view. Personally, I've found a lot more of interest in the "what's not" category in recent weeks than in the "what's hot" category after spending years focused almost entirely on the latter. Stuff like LVMH down 40% in pretty much a straight line because it's facing some headwinds on top of the worst underperformance by European markets vs the US in 20 years.
Hey. Where is the bottom for REGN? It's approaching the 200 DMA, can we expect support there? Does anyone know where large order blocks are waiting to buy up shares?
IMO, LLY/MRK are big pharma companies and at the most basic level, pharma is the major leagues and biotech is the minor leagues. The key hope for biotech investors is that they get bought out by the majors, there aren't tons of biotechs that eventually go on to become big pharma companies themselves - REGN, VRTX are examples, both now with market caps in the neighborhood of $100B. If you're looking at biotech names in the $500M-5B neighborhood, would it be nice if the company went on to become the next REGN? Sure, but top of mind for I think most biotech investors is, would these assets be a good fit for a large pharma looking to fill their pipeline? Investing in biotech in that sort of manner is very volatile at times and in a way almost feels like options (not a perfect comparison) - if you're invested in say a $1B biotech and the key to the thesis is one asset in the pipeline and trial results come out and they're not good, being down 50% instantly is not uncommon. Or it can go the other way if the results are better than expected. I enjoy investing in biotech, but I don't talk about individual names on here really because it is a substantially volatile sector and I don't really "talk my book" on here anymore but especially wouldn't with something like biotech. If you're a big pharma company, things are generally more stable at that point but you still have to continue to succeed. If you are a big pharma company and you consistently overpay for deals and what you do develop has a mixed record of success, then your stock can look like Pfizer's long-term chart does. People can go "but they got a ton of cash from covid vaccines!" Well, the market isn't going to assign that much value if they don't believe it's going to be used well. JNJ is a mix of big pharma and medtech, but even on the medtech side, similar dynamic: people are looking for small medtech companies that would be a fit. I owned Shockwave, which JNJ bought this past Spring.
Am starting to sell some of what's been hot this year and starting to look for ideas in what has been not. LVMH was a name I mentioned earlier. REGN. In terms of themes that have worked this year, I really don't want to add any further to what I already have or am trimming.
So healthcare stocks have never declined because politicians have called for reform, like Clinton did in 1993 or after Hillary's tweet in 2015 about a plan? (https://finance.yahoo.com/news/clintons-bad-news-healthcare-stocks-180659536.html, https://finance.yahoo.com/news/1-tweet-hillary-clinton-sent-122200683.html) Healthcare stocks didn't go down in 2016 because people thought Hillary would win and sold on the impact her plans on reform would have had? https://www.bloomberg.com/news/articles/2016-10-17/health-care-cedes-bull-market-hero-title-as-clinton-lead-widens There was never a dip in things like REGN, which has gone down lately but went on to double from this time period? "Like CVS, or Pfizer? I fail to see a decent example of healthcare company > 100B mkt cap" 1) Pfizer is not a decent healthcare company and I don't know why it seems to be some sort of "go to" reference for big pharma on here and CVS is mediocre. 2) I'm not sure why you are limiting to market cap. 3) I'm not sure why there is some sort of challenge to the idea that stocks ever had a material dip because a politician said they'd fix healthcare.
Some actual DD? I’ve been in a REGN trial for a couple of years and my doctor always fills me in on the deets. They’re really close to approval, the FDA visited the manufacturing site and had some issues they needed to resolve but they’re going to approve it probably in January if not before. Nice dip on REGN as well so I’m going to buy back in soon. The drug is Linvoseltamab, completely eradicated my multiple myeloma with no side effects. It’ll probably become first line treatment with an annual revenue of $8B+
Yes, I agree. It actually even gets a little better. Most people think there will be a buyout at any time by either Merck or REGN. Keep in mind, Keytruda is the # 1 drug on the planet with regard to generating revenue. It generates 25 billion each year and it accounts for 40% of Merck's total revenue. CKPT's Cosibelimab is significantly superior to Keytruda and I doubt Merck will want to lose all that revenue, lol. REGN also recently acquired the Libtayo for 950 million trying to compete with Keytruda, but Cosbelimab is superior to both of them. Most people think a buyout will happen before then end of the year. Merck and REGN have a huge vested interest in the space and CKPT is about to really disrupt it.
Thanks! Agree; there's nothing that I'm really seeing that's on the level of obesity in 2022 or anything AI related (semis, utilities/industrial AI names last year, etc.) The only thing that seems compelling are a handful of high quality businesses that are out of favor and reasonably valued (MPC an example, Couche Tard in Canada kinda interesting near a 52 wk low in the midst of trying to buy out 7-11 parent co) or things that have run into issues lately and are way oversold (REGN), but that's a basket of small/er positions, not something that winds up being one of the larger holdings in the portfolio. "I appreciate you writing out the response " No prob. Honestly, I'd love for more things to be some degree of "forever holdings" - that sort of gradual, 5-10 year ramp of something that's working and you don't have to think about that much - but feels more and more like today if something's really working it becomes this sort of 2-3 year pile on that eventually gets overextended and escalator up/elevator down. Or something gets ahead of itself and then has a muti-year consolidation period. The only places where that doesn't seem to happen as much are the places many don't look: biotech (which is definitely higher risk and very volatile but there are high quality biotechs that have done consistently well over the last 4-5 years) and foreign stocks like all the various UK/Europe roll-ups (Lifco, Judges Scientific, InvestorAB, Addtech, Lagercrantz, etc) that just consistently deliver most years without that much fanfare.
REGN's RSI is at 13. It's ridiculously extremely oversold LMAO
I sold REGN in the $20s back in 2008 for about $100k …. Yeah that’s a painful chart to look at. But not as bad as buy the rumor / sell the news on Steve Jobs return to AAPL Both were multimillion dollar mistakes.
I am up 72% on REGN . Should I sell it all?
$KOLD $AAPL $NVDA $REGN $NVR $VIST $ISRG 
I don't know UTHR but am always interested in new candidates and have been pondering REGN. BTW, I follow HROW closely and they just dropped their sales numbers on IHEEZO it is 2.65x **quarter over quarter** (thats why the big bump today likely). GLTA!
Thanks for these tips, never heard of either but am liking their growth! I recently bought up some UTHR and REGN in the biotech sector
What's in REGN's pipeline that you think will outpace LLY's projected earnings growth from Terzepatide and the upcoming Retatrutide? LLY is eyeballing getting Reta classified for treatment of liver, kidney, and cardiovascular effects, beyond just the obsesity/diabetes application. Honestly asking, I don't know much about REGN's pipline and top prospects, but I know LLY has some best-in-class bangers that could blow the lid off of sales. What's going to drive ratios in 3-5 years? Phase 2, Phase 3 trial top picks? Educate me plz.
What I own that are just individual stocks (doesn't include my ETFs): ABT - just trying to make some money but I don't think it's a long hold ABBV - I'll hold for as long as it makes sense DAR - I might be crazy but I still believe this company has a future and, while I'm at a small loss, I will give it way more time. LOGI -sold half my shares the other day, still haven't decided on the rest NCLH - bought it for options trading but I've been sitting on the fence before I make a decision PL - another option purchase but I don't know, I think I'll stick around for awhile REGN - I hope this stock is the Microsoft of biotech. As of now, it's the smartest purchase I've ever made. WDFC - it's a negative beta stock. Unless something happens to the business, I can't see ever getting rid of it.
REGN > LLY Check it out then spread the word. But really, check it out. Every single ratio is better, including REGNs debt to equity of 10% vs LLY's 205%.
I own REGN (biotech), ABBV (drugs), and ABT (medical devices). If you can eat the price tag, REGN is my first suggestion then ABBV. I'm not going to hold ABT much longer but I plan on holding REGN for as long as makes sense (hopefully for a long ass time) and ABBV when I either hit my gain goal or if I want to put my money to work somewhere else.
I own ABT but I also own ABBV and REGN. I'd take every dollar I put in ABT and instead buy either one if those, mostly REGN. Love that stock.
One hell of a schroedingers story. Same time I think this might be true, or someone's bagholding REGN. Considering the stock performance I am leaning towards the 1st option. So to clarify: Is the doctor hot?
Couple of months she thinks, but could be tomorrow morning for all anyone knows. Could also be priced in, REGN was in the $600s when I first bought.
Aight regards listen up, I had incurable blood cancer until I was cured two years ago by a REGN trial drug. Five minutes ago my doctor told me she’s sure it’s about to be approved as they have majorly ramped up production. Luckily while my doctor is bound by insider trading rules, patients are not. I already made a good bit on regn, but I’m buying back in on any dip in the next couple of months. This drug will be worth at least $8B/yr in revenue and will usurp BMY’s and JNJ’s drugs (revlimid / pomalyst and Darzalex)
Everyone has a story like this one. It is a necessary aspect to learning. Mine was AAPL Buy the rumor when Steve Jobs was going to return in the late 90s I sold on the news of his return and thought I was a genius. If I had held those shares from back then would have been worth millions due to appreciation and multiple splits. Another? REGN interested $100k in shares and sold in $20s back in ‘08 Another multimillion not attained. But we learn from these mistakes, and as shown in other posts… I’ve done ok for myself.
Here are my larger F’up’s 1. AAPL bought 1000 (I think) when rumors of Steve Jobs return … sold on the news… never bought again pre-iPhone I believe at this point the total would be north of $5m But wait there’s more! 2. My inheritance was $100k of REGN stock in 2007 hovering at high teen to low $20 I sold it when it did a breakout at …. $27 … and there’s another $5m I never got. 3. Lessons learned. So I do puts on meme stocks when their valuations go to ludicrous levels… like GME last week. Thanks Roaring Pigeon! Can’t wait for what’s next… AMC?
I got prescribed a drug called Dupixent for eczema. The drug also eliminated my asthma symptoms. Looked up the company that produced it. $REGN it has been a good buy.
So genius moves that weren’t so genius. When rumors of Steve Jobs return to Apple occurred in the mid 90’s, I bought (back then) $1000 worth of shares. When they doubled, I sold (sell the news). Forget 30 years later, even earlier on between splits and growth, this would have been over $1mm years ago. What? Not album enough? I have worse… My father died in 2007, he left me $100k in Regeneron (REGN). It was valued at sub $20 / sh. (FYI that was the full inheritance) I told at $22 If I hold held during the first run up to $600… that’s $3mm If I still held it? ~ $5.5mm So don’t feel bad. I have done some pretty stupid things too. … but don’t cry for me. I’ve done ok.